Andreas Makris

发表

Methods used for multiparameter assay cost-effectiveness literature review

Peter Hall, Andrea Marshall, Nigel Stallard, 2016 .

A Generalized Multi-commodity Location-Allocation Model

Andreas Makris, 1989, J. Inf. Process. Cybern..

Imaging of primary breast cancer with 18F-fluorodeoxythymidine PET-CT reveals heterogeneity of proliferation throughout the tumour

Bal Sanghera, Andreas Makris, Mark Beresford, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

Additional details of the multiparameter tests

Peter Hall, Andrea Marshall, Nigel Stallard, 2016 .

Dynamic contrast-enhanced magnetic resonance imaging and blood oxygenation level-dependent magnetic resonance imaging for the assessment of changes in tumor biology with treatment.

Andreas Makris, A. Padhani, A. Makris, 2011, Journal of the National Cancer Institute. Monographs.

Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer

Andreas Makris, David J Collins, James A d'Arcy, 2008, Clinical Cancer Research.

Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer

Andreas Makris, Frances Daley, Mitch Dowsett, 2006, Breast Cancer Research.

FLT PET-CT in evaluation of treatment response

Bal Sanghera, Andreas Makris, Wai Lup Wong, 2014, Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India.

Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.

Andreas Makris, David J Collins, James A d'Arcy, 2011, Radiology.

Early breast cancer

Andreas Makris, A. Makris, I. Jatoi, 2009, The Lancet.

OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.

John M S Bartlett, Christopher McCabe, Nigel Stallard, 2016, Health technology assessment.

Clinical utility of gene-expression signatures in early stage breast cancer

Andreas Makris, A. Makris, F. Esteva, 2017, Nature Reviews Clinical Oncology.

MRI in the detection and management of breast cancer

Andreas Makris, A. Padhani, A. Makris, 2005, Expert review of anticancer therapy.

Inter‐ and intraobserver variability in the evaluation of dynamic breast cancer MRI

Andreas Makris, D. Collins, A. Padhani, 2006, Journal of magnetic resonance imaging : JMRI.

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Mike Clarke, Yasuo Ohashi, Michael Gnant, 2018, The Lancet. Oncology.

Morphokinetic parameters of early embryo development via time lapse monitoring and their effect on embryo selection and ICSI outcomes: a prospective cohort study

Andreas Makris, Charalampos Siristatidis, Stefano Bettocchi, 2015, Journal of Assisted Reproduction and Genetics.

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.

Andreas Makris, Wolfgang Eiermann, Vered Stearns, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Arterial input functions in dynamic contrast-enhanced magnetic resonance imaging: which model performs best when assessing breast cancer response?

Andreas Makris, Nina Tunariu, David J Collins, 2016, The British journal of radiology.

Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?

Andreas Makris, Richard A Harrison, A. Makris, 2005, International journal of radiation oncology, biology, physics.

Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients

Andreas Makris, Susan G. Hilsenbeck, Frederick L. Baehner, 2008, Breast Cancer Research and Treatment.

Assessing response in breast cancer with dynamic contrast-enhanced magnetic resonance imaging: Are signal intensity–time curves adequate?

David J. Collins, Andreas Makris, Anwar R. Padhani, 2014, Breast Cancer Research and Treatment.

Measuring proliferation in breast cancer: practicalities and applications

Andreas Makris, George D Wilson, A. Makris, 2006, Breast Cancer Research.

Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results.

Carmel Hayes, Andreas Makris, John Suckling, 2006, Radiology.

Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profiles.

Andreas Makris, Adrian L Harris, Francesca M Buffa, 2011, Journal of the National Cancer Institute. Monographs.